Loading…

Surveillance of hand, foot, and mouth disease for a vaccine

[...]the EV71 vaccine reduced the prevalence of EV71-associated hand, foot, and mouth disease and other diseases, suggesting the high efficacy of the vaccine candidate.11 Thus, although EV71 vaccines will probably be available in China soon, several aspects of EV71 immunisation strategies need to be...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet infectious diseases 2014-04, Vol.14 (4), p.262-263
Main Authors: Shimizu, Hiroyuki, Nakashima, Kazutoshi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3
cites cdi_FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3
container_end_page 263
container_issue 4
container_start_page 262
container_title The Lancet infectious diseases
container_volume 14
creator Shimizu, Hiroyuki
Nakashima, Kazutoshi
description [...]the EV71 vaccine reduced the prevalence of EV71-associated hand, foot, and mouth disease and other diseases, suggesting the high efficacy of the vaccine candidate.11 Thus, although EV71 vaccines will probably be available in China soon, several aspects of EV71 immunisation strategies need to be carefully considered before the introduction of these vaccines.
doi_str_mv 10.1016/S1473-3099(13)70330-X
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1511394352</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S147330991370330X</els_id><sourcerecordid>1511394352</sourcerecordid><originalsourceid>FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3</originalsourceid><addsrcrecordid>eNqFkFFLHDEQx0NRqlU_QstCXyy4NbNJbjcISpFqCwd9sIV7C9lkgrF7G012D_z25m5PBV98yjD85j-THyGfgX4HCrPTG-A1KxmV8hjYt5oyRsvFB7Kf27zkXNQ7m3pC9sinlO4ohRoo_0j2Ks4bIWW1T85uxrhC33W6N1gEV9zq3p4ULoThpMhlsQzjcFtYn1AnzP1Y6GKljfE9HpJdp7uER9v3gPy7-vn38lc5_3P9-_LHvDSi4UMJTrSWSZv3ga51xRyHWs9m1rUSGsEAGgpIGdDcrdC0M-loKwRYx03DWnZAjqfc-xgeRkyDWvpkcH0zhjEpEABMciaqjH59g96FMfb5ukxRyUWVRWVKTJSJIaWITt1Hv9TxUQFVa7tqY1et1SlgamNXLfLcl2362C7Rvkw968zAxQRg1rHyGFUyHrNZ6yOaQdng311x_ibBdL73Rnf_8RHT629UqhSdQtYZwDYJC_YEGGmbjQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1509452033</pqid></control><display><type>article</type><title>Surveillance of hand, foot, and mouth disease for a vaccine</title><source>Elsevier</source><creator>Shimizu, Hiroyuki ; Nakashima, Kazutoshi</creator><creatorcontrib>Shimizu, Hiroyuki ; Nakashima, Kazutoshi</creatorcontrib><description>[...]the EV71 vaccine reduced the prevalence of EV71-associated hand, foot, and mouth disease and other diseases, suggesting the high efficacy of the vaccine candidate.11 Thus, although EV71 vaccines will probably be available in China soon, several aspects of EV71 immunisation strategies need to be carefully considered before the introduction of these vaccines.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(13)70330-X</identifier><identifier>PMID: 24485992</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Epidemiology ; Female ; Hand, Foot and Mouth Disease - epidemiology ; Humans ; Immunization ; Infections ; Infectious Disease ; Infectious diseases ; Male ; Public health ; Vaccines</subject><ispartof>The Lancet infectious diseases, 2014-04, Vol.14 (4), p.262-263</ispartof><rights>Elsevier Ltd</rights><rights>2014 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Apr 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3</citedby><cites>FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24485992$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shimizu, Hiroyuki</creatorcontrib><creatorcontrib>Nakashima, Kazutoshi</creatorcontrib><title>Surveillance of hand, foot, and mouth disease for a vaccine</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>[...]the EV71 vaccine reduced the prevalence of EV71-associated hand, foot, and mouth disease and other diseases, suggesting the high efficacy of the vaccine candidate.11 Thus, although EV71 vaccines will probably be available in China soon, several aspects of EV71 immunisation strategies need to be carefully considered before the introduction of these vaccines.</description><subject>Epidemiology</subject><subject>Female</subject><subject>Hand, Foot and Mouth Disease - epidemiology</subject><subject>Humans</subject><subject>Immunization</subject><subject>Infections</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Public health</subject><subject>Vaccines</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqFkFFLHDEQx0NRqlU_QstCXyy4NbNJbjcISpFqCwd9sIV7C9lkgrF7G012D_z25m5PBV98yjD85j-THyGfgX4HCrPTG-A1KxmV8hjYt5oyRsvFB7Kf27zkXNQ7m3pC9sinlO4ohRoo_0j2Ks4bIWW1T85uxrhC33W6N1gEV9zq3p4ULoThpMhlsQzjcFtYn1AnzP1Y6GKljfE9HpJdp7uER9v3gPy7-vn38lc5_3P9-_LHvDSi4UMJTrSWSZv3ga51xRyHWs9m1rUSGsEAGgpIGdDcrdC0M-loKwRYx03DWnZAjqfc-xgeRkyDWvpkcH0zhjEpEABMciaqjH59g96FMfb5ukxRyUWVRWVKTJSJIaWITt1Hv9TxUQFVa7tqY1et1SlgamNXLfLcl2362C7Rvkw968zAxQRg1rHyGFUyHrNZ6yOaQdng311x_ibBdL73Rnf_8RHT629UqhSdQtYZwDYJC_YEGGmbjQ</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>Shimizu, Hiroyuki</creator><creator>Nakashima, Kazutoshi</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20140401</creationdate><title>Surveillance of hand, foot, and mouth disease for a vaccine</title><author>Shimizu, Hiroyuki ; Nakashima, Kazutoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Epidemiology</topic><topic>Female</topic><topic>Hand, Foot and Mouth Disease - epidemiology</topic><topic>Humans</topic><topic>Immunization</topic><topic>Infections</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Public health</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shimizu, Hiroyuki</creatorcontrib><creatorcontrib>Nakashima, Kazutoshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shimizu, Hiroyuki</au><au>Nakashima, Kazutoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surveillance of hand, foot, and mouth disease for a vaccine</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2014-04-01</date><risdate>2014</risdate><volume>14</volume><issue>4</issue><spage>262</spage><epage>263</epage><pages>262-263</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>[...]the EV71 vaccine reduced the prevalence of EV71-associated hand, foot, and mouth disease and other diseases, suggesting the high efficacy of the vaccine candidate.11 Thus, although EV71 vaccines will probably be available in China soon, several aspects of EV71 immunisation strategies need to be carefully considered before the introduction of these vaccines.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>24485992</pmid><doi>10.1016/S1473-3099(13)70330-X</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1473-3099
ispartof The Lancet infectious diseases, 2014-04, Vol.14 (4), p.262-263
issn 1473-3099
1474-4457
language eng
recordid cdi_proquest_miscellaneous_1511394352
source Elsevier
subjects Epidemiology
Female
Hand, Foot and Mouth Disease - epidemiology
Humans
Immunization
Infections
Infectious Disease
Infectious diseases
Male
Public health
Vaccines
title Surveillance of hand, foot, and mouth disease for a vaccine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A38%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surveillance%20of%20hand,%20foot,%20and%20mouth%20disease%20for%20a%20vaccine&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Shimizu,%20Hiroyuki&rft.date=2014-04-01&rft.volume=14&rft.issue=4&rft.spage=262&rft.epage=263&rft.pages=262-263&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(13)70330-X&rft_dat=%3Cproquest_cross%3E1511394352%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c584t-1f5bd39d9921a7a23f417a66dfb9185311801e03107a62ecb69f0b551df4c83b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1509452033&rft_id=info:pmid/24485992&rfr_iscdi=true